Boehringer Ingelheim acquires US cancer company in USD 1.3 billion-deal

Boehringer Ingelheim sees new alternatives in most cancers therapy by way of American Nerio Therapeutics’ checkpoint inhibitors, and the acquisition consists of the acquisition of a preclinical molecule.

发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/boehringer-ingelheim-acquires-us-cancer-company-in-usd-1-3-billion-deal/

(0)
上一篇 3 8 月, 2024
下一篇 3 8 月, 2024

相关推荐

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。